The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer

被引:25
|
作者
Chen, Sufeng [1 ]
Zhang, Jie [1 ]
Li, Xuebing [2 ]
Luo, Xiaoyang [1 ]
Fang, Jing [2 ]
Chen, Haiquan [1 ]
机构
[1] Fudan Univ, Canc Hosp, Inst Canc, Dept Thorac Surg, Shanghai 200032, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
Apoptosis; Bax; Bcl-2; Non-small cell lung cancer; Prolyl hydroxylases; HYPOXIA-INDUCIBLE-FACTOR; ENDOTHELIAL GROWTH-FACTOR; HIF; PROTEIN; APOPTOSIS; FAMILY; ACTIVATION; PHYSIOLOGY; ALPHA; PHD3;
D O I
10.1007/s11010-011-0976-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prolyl hydroxylase domain enzymes (PHDs) play the most notable role in cellular oxygen sensing and oxygen homeostasis, the transcription of PHD genes are involved in the protection against hypoxia and oxidative stress. Intratumoral hypoxia exists in malignant solid tumors primarily due to rapid cancer cell proliferation with high metabolic demands and defective structural and functional vasculature. Previous studies have demonstrated that all the three PHDs have the ability to hydroxylate hypoxia inducible factor (HIF) polypeptides, which are the key molecules in maintaining the oxygen homeostasis. However, PHDs play multiple physiological and pathological roles. There is scant data regarding expression of PHDs genes in non-small cell lung cancer (NSCLC) tissues. In Addition, the relationship between PHDs and apoptosis has never been explored in NSCLC. In this article, we examined the expression of PHD genes and their relationship with the tumor behavior and apoptosis-associated factors in NSCLC. Our results indicated that the expression of PHDs was much higher in lung cancer tissue than that of adjacent normal tissue, and the high expression of PHD3 was associated with early tumor stage and well differentiation in NSCLC. Moreover, increased PHD3 expression was significantly correlated with the low expression of Bcl-2, suggesting its potential role in inducing apoptosis.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 50 条
  • [31] PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin
    Apopa, Patrick L.
    Alley, Lisa
    Penney, Rosalind B.
    Arnaoutakis, Konstantinos
    Steliga, Mathew A.
    Jeffus, Susan
    Bircan, Emine
    Gopalan, Banu
    Jin, Jing
    Patumcharoenpol, Preecha
    Jenjaroenpun, Piroon
    Wongsurawat, Thidathip
    Shah, Nishi
    Boysen, Gunnar
    Ussery, David
    Nookaew, Intawat
    Fagan, Pebbles
    Bebek, Gurkan
    Orloff, Mohammed S.
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [32] Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer
    Wesarg, Emmanuelle
    Hoffarth, Sandra
    Wiewrodt, Rainer
    Kroell, Monika
    Biesterfeld, Stefan
    Huber, Christoph
    Schuler, Martin
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (11) : 2387 - 2394
  • [33] Bcl-2 overexpression enhances in vitro sensitivity against docetaxel in non-small cell lung cancer
    Inoue, Y
    Gika, M
    Abiko, T
    Oyama, T
    Saitoch, Y
    Yamazaki, H
    Nakamura, M
    Abe, Y
    Kawamura, M
    Kobayashi, K
    ONCOLOGY REPORTS, 2005, 13 (02) : 259 - 264
  • [34] Expression of bcl-2, p53 and VEGF in non-small cell lung cancer: Their relation with microvascular density and prognosis
    Yoo, J
    Kim, S
    Shim, B
    Jo, M
    Song, S
    Cho, D
    Ahn, M
    Kim, C
    Cho, K
    Kim, H
    LUNG CANCER, 2005, 49 : S299 - S299
  • [35] BCL-2 expression as an apoptotic index in non small cell lung carcinomas
    Kalogeraki, A
    Kozoni, V
    Zoras, O
    Tamiolakis, D
    Panayiotides, J
    Charakidas, A
    Chalkiadakis, G
    Bouros, D
    Stathopoulos, E
    Delides, GS
    IN VIVO, 2001, 15 (01): : 53 - 56
  • [36] Antisense bcl-2 treatment increases programmed cell death in non-small cell lung cancer cell lines
    Koty, PP
    Zhang, HF
    Levitt, ML
    LUNG CANCER, 1999, 23 (02) : 115 - 127
  • [37] Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer
    Oshika, Y
    Masuda, K
    Tokunaga, T
    Hatanaka, H
    Kamiya, T
    Abe, Y
    Ozeki, Y
    Kijima, H
    Yamazaki, H
    Tamaoki, N
    Ueyama, Y
    Nakamura, M
    CLINICAL CANCER RESEARCH, 1998, 4 (07) : 1785 - 1788
  • [38] IS BCL-2 IMPORTANT IN SMALL CELL LUNG CANCER?
    Lawson, M. H.
    Rassl, D. M.
    Vowler, S. L.
    Cummings, N. M.
    Howat, W. J.
    Murphy, G.
    Rintoul, R. C.
    THORAX, 2010, 65 : A43 - A43
  • [39] Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo
    Zhang, Haiping
    Sui, Aihua
    Wang, Zhenli
    Liu, Shihai
    Yao, Ruyong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 (02) : 358 - 364
  • [40] The expression of salvage pathway enzymes in non-small cell lung cancer cells
    Townsend, Michelle H.
    Weagel, Evita G.
    Anderson, Michael D.
    Velazquez, Edwin
    Robison, Richard A.
    O'Neill, Kim L.
    CANCER RESEARCH, 2017, 77